| 生物活性 |
Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPα antibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab . Anzurstobart has the potential for solid and hematologic malignancies research.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子量 |
144.66 kDa
|
||||||||||||
| CAS号 |
2543693-10-1
|
||||||||||||
| 运输条件 |
Shipping with dry ice.
|
||||||||||||
| 储存方式 |
|
纯度： 98%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet